THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Ibex Investors LLC's Holding History (CIK: 0001531964)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019

Shares 45,225 Value ($000) $739 Avg Close $20.26 Range $15.18 - $25.38

Q1 2019

Shares 32,123 Value ($000) $728 Avg Close $25.36 Range $21.04 - $28.63

Q4 2018

Shares 35,804 Value ($000) $916 Avg Close $27.00 Range $21.70 - $35.48

Q3 2018

Shares 46,101 Value ($000) $1,506 Avg Close $27.25 Range $22.26 - $32.79

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2019	45,225	$739	$20.26	$15.18 - $25.38
Q1 2019	32,123	$728	$25.36	$21.04 - $28.63
Q4 2018	35,804	$916	$27.00	$21.70 - $35.48
Q3 2018	46,101	$1,506	$27.25	$22.26 - $32.79